Summary
The sera of 30 patients suffering from schizophrenia (DSM III) and 30 neurological controls were tested for antibrain antibodies in a blind indirect immunofluorescence assay. We found IgG- and IgM-binding in the sera of 22 patients, but only 4 out of the 30 age- and sex-matched controls. The binding was mainly directed to neurons from the frontal cortex and septal area, areas, which are regarded as important in the development of schizophrenic illness. These preliminary data are presented, to encourage other immunological studies in schizophrenia research.
Similar content being viewed by others
References
Aarli JA, Aparicio SR, Lumsden CE, Tönder O (1975) Binding of normal human IgG to myelin sheaths, glia and neurons. Immunology 28:171–185
Ahokas A, Koskiniemi M-L, Vaheri A, Rimón R (1985) Altered white cell count, protein concentration and oligoclonal IgG bands in the csf of many patients with acute psychiatric disorders. Neuropsychobiology 14:1–4
Axelsson R, Martensson E, Alling C (1982) Impairment, of the blood-brain barrier as an aetiological factor in paranoid psychosis. Br J Psychiatry 141:273–281
Baron M, Stern M, Anavi R, Witz IP (1977) Tissue-binding factor in schizophrenic sera: a clinical and genetic study. Biol Psychiatry 12:199–219
Bergen JR, Grinspoon L, Pyle HM, Martinez JL, Pennell RB (1980) Immunologic studies in schizophrenic and control subjects. Biol Psychiatry 15:369–379
Bock E, Weeke B, Rafaelsen OJ (1971) Serum proteins in acutely psychotic patients. J Psychiatr Res 9:1–9
Boehme DH, Cottrell JC, Dohan FC, Hillegass LM (1974) Demonstration of nuclear and cytoplasmic fluorescence in brain tissues of schizophrenic and nonschizophrenic patients. Biol Psychiatry 8:89–94
Bogerts B, Meertz E, Schönfeldt-Bausch R (1985) Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 42:784–791
Burch PRJ (1964) Schizophrenia: some new aetiological considerations. Br J Psychiatry 110:818–824
DeLisi LE, Crow TJ (1986) Is schizophrenia a viral or immunologic disorder? Psychiatr Clin North Am 9:115–132
DeLisi LE, Weinberger DR, Potkin S, Neckers LM, Shiling DJ, Wyatt RJ (1981) Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients. Br J Psychiatry 139:513–518
DeLisi LE, Weber RJ, Pert CB (1985) Are there antibodies against brain in sera from schizophrenic patients? Review and prospectus. Biol Psychiatry 20:110–115
Ehrnst A, Wiesel F-A, Bjerkenstedt L, Tribukait B, Jonsson J (1982) Failure to detect immunologic stigmata in schizophrenia. Neuropsychobiology 8:169–171
Falkai P, Bogerts B, Rozumek M (1988) Limbic pathology in schizophrenia: the entorhinal region — a morphometric study. Biol Psychiatry 24:515–521
Fudenberg HH, Whitten HD, Chou YK, Arnaud P, Shums AA, Khansari NK (1984) Sigma receptors and autoimmune mechanisms in schizophrenia: preliminary findings and hypotheses. Biomed Pharmacother 38:285–290
Heath RG, Krupp IM (1967) Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques. Arch Gent Psychiatry 16:1–9
Heath RG, McCarron KL, O'Neil CE (1989) Antiseptal brain antibody in IgG of schizophrenic patients. Biol Psychiatry 25:725–733
Henneberg A, Riedl B, Dumke HO, Kornhuber HH (1990) T-lymphocyte subpopulations in schizophrenic patients. Eur Arch Psychiatr Neurol Sci 239:283–284
Jakob H, Beckmann H (1989) Gross and histological criteria for developmental disorders in brains of schizophrenics. J R Soc Med 82:466–469
Kagami M, Koike T, Maruyama N, Takabayashi K, Tomioka H, Yoshida S, Kon Y (1987) Cytotoxic anti-lymphocyte antibody in schizophrenics. J Neurol 234:359–360
Kaiya H, Kematsu M, Ofuji M, Nishida A, Morikiyo M, Adachi S (1989) Computerised tomography in schizopheria. Familial versus non-famkilial forms of illness. Br J Psychiatry 155:444–450
Kelly RH, Ganguli R, Rabin BS (1987) Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia. Biol Psychiatry 22:1488–1491
Knight JG, Knight A, Pert CB (1987) Is schizophrenia a virally triggered antireceptor autoimmune disease? In: Helmchen H, Henn FA (eds) Biological Perspectives of Schizophrenia. John Wiley & Sons, pp 107–127
Knight JG, Knight A, Menkes DB, Mullen PE (1990) Autoantibodies against brain septal region antigens specific to unmedicated schizophrenia. Biol Psychiatry 28:467–474
Koliaskina G, Tsutsulkovskaya M, Domashneva I, Maznina T, Kielholz P, Gastpar M, Bunney W, Rafaelsen O, Heltberg J, Coppen A, Hippius H, Hoecherl B, Vartanian F (1980) Antithymic immune factor in schizophrenia. A world health organization study. Neuropsychobiology 6:349–355
Kornhuber HH, Kornhuber J (1987) A neuroimmunological challenge: schizophrenia as an autoimmune disease. Arch Ital Biol 125:271–272
Kornhuber J, Bauer K (1986) Störung der Blut-Liquor-Schranke bei Schizophrenie. Dtsch Med Wschr 26:1041
Lefvert AK, Pirskanen R, Eng H Sundevall A-C, Svanborg E (1989) B cell and autoantibody repertoire in a pair of monozygotic twins discordant for myasthenia gravis. Clin Immunol Immunopathol 53:161–170
Legros S, Mendlewicz J, Wybran J (1985) Immunoglobulins, autoantibodies and other serum protein, fractions in psychiatric disorders. Eur Arch Psychiatr Neurol Sci 235:9–11
Lehmann-Facius H (1937) Über die Liquordiagnose der Schizophrenien. Klin. Wochenschr 16:1646–1648
Leonardi A, Cocito L, Tabaton M, Bartolini A, Roccatagliata G (1982) CSF and serum IgG and albumin in schizophrenia. IRCS Medical Science Immunlogy and Allergy 10:812–813
Logan DG, Deodhar SD (1970) Schizophrenia, an immunologic disorder? JAMA 212, 10:1703–1704
Martin-du Pan R, Dayer JM (1982) Actions des neurotransmetteurs et des medicaments psychotropes sur le systeme immunitaire. Schweiz Med Wschr 112:1910–1920
Müller N, Hofschuster E, Ackenheil M (1989) Quantifizierung zellulärer Immunfunktionen als State- bzw. Trait-Marker. In: Saletu B (ed) Biologische Psychiatrie. 2. Drei-Länder-Symposium Innsbruck, September 1988. Thieme Verlag, Stuttgart, New York, pp 113–118
Pandey RS, Gupta AK, Chaturvedi UC (1981) Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol Psychiatry 16,12:1123–1136
Pulkkinen E (1977) Immunoglobulins, psychopathology and prognosis in schizophrenia. Acta Psychiatr Scand 56:173–182
Roos RP, Davis K, Meltzer HY (1985) Immunoglobulin studies in patients with psychiatric diseases. Arch Gen Psychiatry 42:124–128
Rubin RT (1965) Investigation of precipitins to human brain in sera of psychotic patients. Br J Psychiatry 111:1003–1006
Saunders JC, Muchmore E (1964) Phenothiazine effect on human antibody synthesis. Br J Psychiatry 110:84–89
Solomon GF, Allansmith M, McClelan B, Amkraut A (1969) Immunoglobulins in psychiatric patients. Arch Gen Psychiatry 20:272–277
Strahilevitz M, Davis SD (1970) Increased IgA in schizophrenic patients. Lancet II:370
Takada A, Takada Y, Ito U, Minowada J (1974) Shared antigenic determinants betwen human brain and human T-cell line. Clin Exp Immunol 18:491–498
Thompson RA (1988) Laboratory investigations in clinical immunology: methods, pitfalls and clinical indications Clin Exp Immunol 74:494–503
Vartanian ME, Kolyaskina GI, Lozovsky DV, Burbaeva GS, Ignatov SA (1978) Aspects of humoral and cellular immunity in schizophrenia. In: Bergsma, Daniel (eds) Neurochemical and immunologic components in schizophrenia. Birth Defects XIV,5. Liss New York, pp 339–364
Von Brauchitsch H (1972) Antinuclear factor in psychiatric disorder. Am J Psychiatry 128:1552–1554
Watanabe M, Funahashi T, Suzuki T, Nomura, S, Nakazawa T, Noguchi T, Tsukada Y (1982) Antithymic antibodies in schizophrenic sera. Biol Psychiatry 17:699–710
Whittingham S, Mackay IR, Jones IH, Davies B (1968) Absence of brain antibodies in patients with schizophrenia. BMJ 1:347–348
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Henneberg, A.E., Ruffert, S., Henneberg, HJ. et al. Antibodies to brain tissue in sera of schizophrenic patients. Eur Arch Psychiatry Clin Nuerosci 242, 314–317 (1993). https://doi.org/10.1007/BF02190392
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02190392